Filing Details
- Accession Number:
- 0001209191-20-027906
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-08 16:28:00
- Reporting Period:
- 2020-05-06
- Accepted Time:
- 2020-05-08 16:28:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1789815 | Ourania Tatsis | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Chief Regulatory Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-06 | 559 | $187.53 | 13,297 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-06 | 407 | $155.57 | 13,704 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-06 | 43 | $268.80 | 13,661 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 136 | $270.19 | 13,525 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 217 | $272.09 | 13,308 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 210 | $273.15 | 13,098 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 330 | $274.13 | 12,768 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 30 | $275.30 | 12,738 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-06 | 559 | $0.00 | 559 | $187.53 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-06 | 407 | $0.00 | 407 | $155.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,145 | 2029-02-05 | No | 4 | M | Direct | |
| 2,854 | 2028-02-05 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $268.80 (range $268.65 to $269.12).
- Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $270.19 (range $269.71 to $270.61).
- Open market sales reported on this line occurred at a weighted average price of $272.09 (range $271.73 to $272.54).
- Open market sales reported on this line occurred at a weighted average price of $273.15 (range $272.73 to $273.50).
- Open market sales reported on this line occurred at a weighted average price of $274.13 (range $273.75 to $274.73).
- The option vests in 16 quarterly installments from 02/06/2019.
- The option vests in 16 quarterly installments from 02/06/2018.
Billionaire Hedge Funds
